why choose us

Clinical Trials Search

Showing 11,000 of 132,366 result(s)
Assessing the Effects of ELO Water on Diabetic Foot Ulcers

Status: COMPLETED

Condition: Foot Ulcer, Diabetic

Interventions: Drinking 1.5 litres daily of ELO water for 12 weeks

Date: 2023-06-04

Mercer's Maternal Role

Status: NOT_YET_RECRUITING

Condition: Pregnancy Related

Interventions: Pregnant women in the experimental group will be given training and counseling based on the maternal role theory, starting at 32 weeks of gestation (1

Date: 2023-06-04

Using Acetylcysteine and Vitamin E With Psoriasis Vulgaris

Status: Completed

Condition: Psoriasis Vulgaris

Interventions: N-acetyl cysteine (NAC) is synthetic cysteine amino acid, which in turn elevate the glutathione level in the body, which have important direct antioxi

Date: 2023-06-04

PUSH-IT Continuing Enteral Feeds for Tracheostomy

Status: Completed

Condition: Tracheostomy Complication

Interventions: Enteral feeds are continued up until time of surgery

Date: 2023-06-04

Methods That Reduce Pain During Debonding Fixed Orthodontic Appliance

Status: Completed

Condition: Pain

Interventions: the pain is recorded when the patient is biting on the mouthpiece of the device during the debonding procedure

Date: 2023-06-04

Risk Factors for Prolonged Mechanical Ventilation in Elevated Mean Airway Pressure

Status: Completed

Condition: Mechanical Ventilation Pressure High

Interventions: Invasive mechanical ventilation for patients admitted to the ICU

Date: 2023-06-04

The BETY-Biopsychosocial Questionnaire (BETY-BQ) in Individuals With Temporomandibular Dysfunction-Related Headache

Status: Completed

Condition: Temporomandibular Disorders

Interventions:

Date: 2023-06-04

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients

Status: NOT_YET_RECRUITING

Condition: SMA II

Interventions: Self-complementary AAV9 carrying a codon-optimized SMN coding sequence(coSMN1) driven by CMV enhancer and chicken ?-actin promoter

Date: 2023-06-04

Venetoclax Combined With Azactidine in the Treatment of ALAL

Status: Completed

Condition: Acute Leukemia of Ambiguous Lineage

Interventions: Venetoclax orally once daily (100 mg d1, 200 mg d2, 400 mg d3-28);

Date: 2023-06-04

Pre-Surgical Grading System of Asherman Syndrome

Status: COMPLETED

Condition: Asherman Syndrome

Interventions: Novel Asherman Scoring Classification

Date: 2023-06-04